DEF DOWNLOAD

Your source for all the latest digital offerings from the DEF

Digital Newsletter

DEFinitely is the digital newsletter from the Dermatology Education Foundation designed to keep you up to date on all the latest offerings from the DEF. Check back for regular updates or register for email updates

Issue 5: September 2023

Issue 4 : August 2023

Issue 3: July 2023

Issue 2: June 2023

Issue 1 : May 2023

Dermalorian™ Webinar Series

The Dermalorian™ Webinar series offers updates on patient care, therapeutic advancements, professional development, and more. 

The Dermalorian Podcast

Follow our Podcast using one of the providers below!

LATEST EPISODE:

  • Dermatopathology isn’t typically meant to provide definitive diagnosis. But it can give important information for supporting a diagnosis and guiding patient care. Michelle Hure, MD, founder of OC Skin Lab in Orange County, CA, shares 10 tips for getting better results from a dermatopathologist. Also in this edition, Michelle Sullentrup of MyDermRecruiter.com talks about measuring production and David Cohen, MD, MPH talks about when and how to suspect dupilumab failure.

Previous Episodes:

In the Know Video Series

Are you “In the Know”? Follow @DermNPPA on Facebook, Instagram, or LinkedIn to catch up on these brief, insightful videos intended especially for NPs and PAs in Dermatology.

Topical Treatments to Boost Biologics

Featuring: Kara Gooding, MS, PA-C

Despite the efficacy of biologics for psoriasis, some patients need additional treatment to achieve clear skin. Kara Gooding, MS, PA-C discusses the role for topical treatment to support patient care by dermatology nurse practitioners and physician assistants.

What is a Biosimilar?

Featuring: Kara Gooding, MS, PA-C

Coming soon to dermatology: biosimilars. Though several have been approved, these agents are just coming to market. Kara Gooding, MS, PA-C explains what they are and how they may be used in patient care by dermatology nurse practitioners and physician assistants.

JAK Inhibitors for Vitiligo

Featuring: David E. Cohen, MD, FAAD

Topic JAK inhibitors are now FDA approved for treatment of vitiligo. David E. Cohen, MD discusses medical treatment of this “devastating disease,” and describes the use of new topical treatments.

The Impact of Inflammatory Skin Diseases

Featuring: Joseph Gorelick, MSN, FNP-C

Inflammatory skin diseases and their comorbidities can have a major impact on affected patients. Discover how atopic dermatitis and psoriasis affects patients and how to help them from Joseph Gorelick, MSN, FNP-C of DEF.

Inflammation is at the Heart of Psoriasis and AD

Featuring: Joseph Gorelick, MSN, FNP-C

Did you know that systemic inflammation is at the heart of atopic dermatitis and psoriasis? Learn about the skin manifestations of inflammation from Joe Gorelick FNP-C of The Dermatology Education Foundation.

Get to Know the Biologic Cheat Sheet

Featuring: Kara Gooding, MMS, PA-C

Need a guide to treatments for psoriasis and atopic dermatitis? Get the cheat sheet from the DEF Biologics and Small Molecule Bootcamp.